Your Searchlight for Allogeneic
Cell Therapy Success
Our mission is to help Searchlight members increase their business through a structured, positive and professional program that enables them to develop long-term, meaningful relationships with the most engaged stakeholders in key scientific communities.
Searchlight gives life science leaders clarify to see where opportunity lies. Helping companies to move forward faster is at the heart of the network.
We are the custodians of the Allogeneic Cell Therapy: Searchlight communities on behalf of our members; engaged in the constant pursuit of added value.
The quality of information is the difference between success and failure. Searchlight is the destination to find the latest information, trends and solutions impacting the Allogeneic Cell Therapy industry.
Building strong relationships creates an environment of trust and support that yields opportunity, progress, partnership and meaning.
The feedback from members speaks for itself…
Oliver Kraemer, Head of Gene Edited Platforms, BMS
“This is such a fast moving field and we’re all learning together. Every new paper published and every new clinical trial adds more to the picture. There is huge benefit of strategic exchange in sharing what’s working and what’s not”
Iulia Diaconu, VP Immunotherapy, ElevateBio
"Searchlight: Allogeneic Cell Therapy offers connections and insights that aren't possible to access anywhere else, and gives us the opportunity to collaborate and build partnerships to help us all move forward in ways we wouldn’t otherwise have been able to."
Carlos Yuraszeck, Executive Director of GMP Operations, Astellas
"It's possible in our industry to become very isolated and insular, but what's clear to me is that we can’t really do this on our own as effectively as if we work together: it’s way too complicated, there are too many moving parts. For the good of the community, the industry and our patients, we should be actively looking for opportunities to learn from each other, and this is a perfect chance to do just that."
For more reviews about Allogeneic Cell Therapy: Searchlight membership, head to our testimonials page. and hear directly from our members about why they've joined.
Meet our team
Gareth established and is responsible for developing the strategic direction of the Searchlight business within Hanson Wade, ensuring continues to add demonstrable value to every member as it scales. Gareth has successfully built and grown information businesses in the US, Europe, Asia and the Middle East during a 20 year entrepreneurial career. He holds a first class degree in Politics and earned a postgraduate Certificate in International Business Practice from the Mountbatten Institute in New York.
Community Development Manager
Jonty achieved his undergraduate degree in Biological Sciences at Portsmouth university before joining Hanson Wade in 2022. Initially joining the company as a conference producer, he now works in Searchlight and delivers year-round value to network members. His work serves as a catalyst for drug developers in the allogeneic and RAS-targeted therapeutic fields, bringing together highly invested companies to collaborate and share experiences.
Following the completion of her degree in Nutritional Science at Newcastle University, Grace's career at Hanson Wade originally began in Delegate Sales. Grace have now moved over to Searchlight where she is responsible for establishing new members to join a range of our Expert Networks. Grace is keen to help current and future members drive progress within their work and connect with the leading minds within their industry’s and to ultimately get the most value possible from Searchlight Networks.